I think GSK had a stab at a herpes vaccine a few years ago. They hit a brick wall at the Phase 3 trial phase. A GSK like Big Pharma will be needed to fund late stage trials.
Will be interesting to see if authorities include a future preventative herpes vaccine on the immunization schedule. It will need to satisfy a number of requirements including whether the vaccination is a priority. Apart from neonate herpes, herpes doesnt damage any vital organs and doesnt lead to death in people so, in a world of tight health budgets and competing health priorities, it may not be considered a huge priority.
I personally believe because it has relatively minor morbidity issues I reckon the health authorities might be inclined to wait until they have years (maybe decades) of data behind it before its put on a universal vaccination schedule. It doesnt prevent people from getting a vax in the meantime, they just have to pay for it from their own pocket.
AHZ Price at posting:
6.9¢ Sentiment: Buy Disclosure: Not Held
(20min delay)